AWM
TTOO

AE Wealth Management’s T2 Biosystems, Inc TTOO Stock Holding History

AE Wealth Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$6K – 1934
2022
Q3 		$6K Buy
10
+3
+43% +$1.97K ﹤0.01% 1733
2022
Q2 		$6K Hold
7
– – ﹤0.01% 1709
2022
Q1 		$19K Hold
7
– – ﹤0.01% 1651
2021
Q4 		$18K Buy
7
+2
+40% +$6.96K ﹤0.01% 1681
2021
Q3 		$23K Buy
5
+1
+25% +$5.03K ﹤0.01% 1591
2021
Q2 		$21K Buy
+4
New +$25.8K ﹤0.01% 1556

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AE Wealth Management's TTOO Position: Q4 2022 in Review

AE Wealth Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 10 shares — an estimated $6K sold.

AE Wealth Management first reported a position in TTOO in Q2 2021 and held it in 6 quarters. The position peaked at $23K in Q3 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • AE Wealth Management reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • AE Wealth Management sold 10 T2 Biosystems, Inc shares in Q4 2022, an estimated $6K.
  • AE Wealth Management first reported a position in T2 Biosystems, Inc in Q2 2021 and held it in 6 quarters.
  • AE Wealth Management's T2 Biosystems, Inc position peaked at $23K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on AE Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.